PT2003136T - Processo para a produção de cloridrato de prasugrel de elevada pureza - Google Patents

Processo para a produção de cloridrato de prasugrel de elevada pureza

Info

Publication number
PT2003136T
PT2003136T PT77412211T PT07741221T PT2003136T PT 2003136 T PT2003136 T PT 2003136T PT 77412211 T PT77412211 T PT 77412211T PT 07741221 T PT07741221 T PT 07741221T PT 2003136 T PT2003136 T PT 2003136T
Authority
PT
Portugal
Prior art keywords
producing high
prasugrel hydrochloride
purity prasugrel
purity
hydrochloride
Prior art date
Application number
PT77412211T
Other languages
English (en)
Inventor
Hagihara Masahiko
Inoue Teruhiko
Nakamura Kazuyoshi
Miyata Hiroyuki
Wada Yukinori
Yokota Naoyuki
Original Assignee
Ube Industries
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38563784&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2003136(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ube Industries, Daiichi Sankyo Co Ltd filed Critical Ube Industries
Publication of PT2003136T publication Critical patent/PT2003136T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT77412211T 2006-04-06 2007-04-06 Processo para a produção de cloridrato de prasugrel de elevada pureza PT2003136T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006105555 2006-04-06
JP2007053094 2007-03-02

Publications (1)

Publication Number Publication Date
PT2003136T true PT2003136T (pt) 2017-04-20

Family

ID=38563784

Family Applications (1)

Application Number Title Priority Date Filing Date
PT77412211T PT2003136T (pt) 2006-04-06 2007-04-06 Processo para a produção de cloridrato de prasugrel de elevada pureza

Country Status (24)

Country Link
US (1) US8193358B2 (pt)
EP (1) EP2003136B1 (pt)
JP (1) JP5289940B2 (pt)
KR (1) KR101375469B1 (pt)
AU (1) AU2007234467B2 (pt)
BR (1) BRPI0709739A2 (pt)
CA (1) CA2648503C (pt)
CO (1) CO6140036A2 (pt)
CY (1) CY1118816T1 (pt)
DK (1) DK2003136T3 (pt)
ES (1) ES2622514T3 (pt)
IL (1) IL194522A (pt)
LT (1) LT2003136T (pt)
MX (1) MX2008012930A (pt)
MY (1) MY151441A (pt)
NO (1) NO342060B1 (pt)
NZ (1) NZ571746A (pt)
PL (1) PL2003136T3 (pt)
PT (1) PT2003136T (pt)
RU (1) RU2424243C2 (pt)
SG (1) SG185146A1 (pt)
SI (1) SI2003136T1 (pt)
TW (1) TWI392681B (pt)
WO (1) WO2007114526A1 (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2123656B1 (en) * 2007-03-02 2014-06-11 Daiichi Sankyo Company, Limited Process for production of prasugrel hydrochloride having high purity
WO2009062044A2 (en) * 2007-11-09 2009-05-14 Dr. Reddy's Laboratories Ltd. Processes for the preparation of prasugrel, and its salts and polymorphs
WO2009066326A2 (en) * 2007-11-19 2009-05-28 Msn Laboratories Limited Improved process for the preparation of prasugrel and its pharmaceutically acceptable salts
HU230261B1 (hu) * 2007-11-27 2015-11-30 Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság Eljárás gyógyszeripari intermedierek előállítására
EP2257556A1 (en) 2008-02-06 2010-12-08 Helm AG Prasugrel salts with improved properties
WO2009129983A1 (en) * 2008-04-21 2009-10-29 Ratiopharm Gmbh Acid addition salts of prasugrel and pharmaceutical compositions comprising the same
PL2112155T3 (pl) * 2008-04-25 2011-03-31 Sandoz Ag Wodorosiarczan (VI) 2-acetoksy-5-(α-cyklopropylokarbonylo-2-fluorobenzylo)-4,5,6,7-tetrahydrotieno[3,2-c]pirydyny i sposób jego otrzymywania
WO2010070677A2 (en) * 2008-12-15 2010-06-24 Glenmark Generics Limited A process for the preparation of prasugrel and its pharmaceutically acceptable salts thereof
GB2469883A (en) * 2009-04-30 2010-11-03 Sandoz Ag Novel crystalline form of Prasugrel hydrogensulphate
EP2451816A4 (en) * 2009-07-06 2013-02-27 Glenmark Generics Ltd CRYSTALLINE FORM OF PRASUGREL HYDROBROMIDE AND PROCESS FOR PREPARING THE SAME
KR20110015254A (ko) * 2009-08-07 2011-02-15 한미홀딩스 주식회사 프라수그렐 디술폰산염 및 이의 결정
CN101993447A (zh) * 2009-08-26 2011-03-30 浙江华海药业股份有限公司 一种人工合成普拉格雷的方法
KR20110024057A (ko) * 2009-09-01 2011-03-09 한미홀딩스 주식회사 신규한 프라수그렐 황산수소염의 결정다형
US20120202066A1 (en) * 2009-10-07 2012-08-09 Manne Satyanarayana Reddy Processes For Preparing Prasugrel And Pharmaceutically Acceptable Salts Thereof
CZ2009762A3 (cs) 2009-11-16 2011-05-25 Zentiva, K. S. Nové soli 5-[2-cyklopropyl-1-(2-fluorfenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetátu známého pod nechráneným názvem prasugrel a zpusob jejich výroby
CZ302796B6 (cs) * 2009-11-16 2011-11-16 Zentiva, K. S. Cyklamát 5-[2-cyklopropyl-1-(2-fluorfenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetátu známého pod nechráneným názvem prasugrel a zpusob jeho výroby
CZ2009763A3 (cs) * 2009-11-16 2011-05-25 Zentiva, K. S. Zpusob výroby vysoce cistého 5-[2-cyklopropyl-1-(2-fluorfenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetátu známého pod nechráneným názvem prasugrel a jeho nových farmaceuticky prijatelných solí.
CZ2009828A3 (cs) 2009-12-09 2011-06-22 Zentiva, K.S. Zpusob prípravy hydrochloridu 5-[2-cyklopropyl-1-(2-fluorfenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetátu (prasugrelu hydrochloridu) v polymorfní forme B
HU229035B1 (en) 2009-12-21 2013-07-29 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Process for producing prasurgel
HU229031B1 (en) 2009-12-21 2013-07-29 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Process for producing prasurgel and its intermediate
CN102869668A (zh) 2010-03-09 2013-01-09 斯索恩有限公司 制备普拉格雷的方法
CN102190569B (zh) * 2010-03-12 2014-07-02 浙江海翔药业股份有限公司 一种普拉格雷中间体α-环丙基羰基-2-氟苄基溴的制备方法
WO2011117782A1 (en) * 2010-03-23 2011-09-29 Alembic Pharmaceuticals Limited A process for the preparation of prasugrel hcl salt
HRP20150356T1 (hr) 2010-04-08 2015-05-08 Teva Pharmaceutical Industries Ltd. Kristalni oblici soli prasugrela
WO2012018791A2 (en) * 2010-08-06 2012-02-09 Dr. Reddy's Laboratories Ltd. Preparation of prasugrel hydrochloride
WO2012023145A2 (en) * 2010-08-18 2012-02-23 Hetero Research Foundation Prasugrel hydrochloride crystalline particles
HUP1000565A2 (en) 2010-10-22 2012-05-02 Egis Gyogyszergyar Nyrt Process for the preparation of pharmaceutically active compound and intermediers
GEP20217235B (en) 2011-02-10 2021-03-25 Inc Exelixis Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds
CN102838618A (zh) 2011-06-22 2012-12-26 广东东阳光药业有限公司 一种制备普拉格雷的方法及普拉格雷盐酸盐新晶型
BR112013033464A2 (pt) * 2011-06-27 2017-01-24 Ipca Lab Ltd composto, acetato, composição farmacêutica, combinação farmacêutica, método e método melhorado
CN102898437A (zh) * 2011-07-21 2013-01-30 四川海思科制药有限公司 一种普拉格雷的酸加成盐及其制备方法和用途
JP2014524929A (ja) * 2011-07-28 2014-09-25 ラボラトリオス レスヴィ，エス．エル． プラスグレルの調製方法
ITMI20121494A1 (it) * 2012-09-07 2014-03-08 Erregierre Spa Processo per la produzione di prasugrel cloridrato
PL402028A1 (pl) 2012-12-12 2014-06-23 Instytut Farmaceutyczny Sposób wytwarzania postaci polimorficznej B chlorowodorku prasugrelu o czystości farmaceutycznej
CN107698620A (zh) 2015-06-23 2018-02-16 江苏天士力帝益药业有限公司 一种氘代噻吩并哌啶衍生物、制备方法及其应用
HU231079B1 (hu) 2016-06-23 2020-06-29 Richter Gedeon Nyrt. Eljárás nagytisztaságú Prasugrel előállítására bromopentil szennyezés eltávolításával

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3736664A1 (de) * 1987-10-29 1989-05-11 Boehringer Ingelheim Kg Tetrahydro-furo- und -thieno(2,3-c)pyridine, ihre verwendung als arzneimittel und verfahren zu ihrer herstellung
FI101150B (fi) * 1991-09-09 1998-04-30 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten tetrahydrotienopyridiinin johd annaisten valmistamiseksi
JP3840662B2 (ja) 1994-10-07 2006-11-01 宇部興産株式会社 ２−シリルオキシ−テトラヒドロチエノピリジン類、その塩およびその製造方法
DE19931993A1 (de) 1999-07-09 2001-01-11 Coronet Werke Gmbh Verfahren und Vorrichtung zur Herstellung von Borsten
EP1298132B1 (en) * 2000-07-06 2006-11-22 Sankyo Company, Limited Hydropyridine derivative acid addition salts
JP4001199B2 (ja) 2000-07-06 2007-10-31 第一三共株式会社 ヒドロピリジン誘導体酸付加塩
WO2009129983A1 (en) 2008-04-21 2009-10-29 Ratiopharm Gmbh Acid addition salts of prasugrel and pharmaceutical compositions comprising the same
GB2469883A (en) 2009-04-30 2010-11-03 Sandoz Ag Novel crystalline form of Prasugrel hydrogensulphate

Also Published As

Publication number Publication date
PL2003136T3 (pl) 2017-06-30
CY1118816T1 (el) 2018-01-10
IL194522A0 (en) 2009-08-03
NO20084678L (no) 2008-11-05
KR101375469B1 (ko) 2014-03-18
AU2007234467B2 (en) 2012-03-22
LT2003136T (lt) 2017-04-10
JP5289940B2 (ja) 2013-09-11
RU2008144008A (ru) 2010-05-20
RU2424243C2 (ru) 2011-07-20
US8193358B2 (en) 2012-06-05
EP2003136A4 (en) 2010-01-20
TWI392681B (zh) 2013-04-11
EP2003136A1 (en) 2008-12-17
AU2007234467A1 (en) 2007-10-11
WO2007114526A1 (ja) 2007-10-11
CA2648503A1 (en) 2007-10-11
JPWO2007114526A1 (ja) 2009-08-20
CA2648503C (en) 2013-12-17
MY151441A (en) 2014-05-30
CO6140036A2 (es) 2010-03-19
SI2003136T1 (sl) 2017-04-26
EP2003136B1 (en) 2017-01-18
KR20080110777A (ko) 2008-12-19
NO342060B1 (no) 2018-03-19
DK2003136T3 (da) 2017-05-01
TW200813068A (en) 2008-03-16
BRPI0709739A2 (pt) 2011-07-26
SG185146A1 (en) 2012-11-29
ES2622514T3 (es) 2017-07-06
MX2008012930A (es) 2008-10-15
US20090203729A1 (en) 2009-08-13
NZ571746A (en) 2011-12-22
IL194522A (en) 2015-09-24

Similar Documents

Publication Publication Date Title
LT2003136T (lt) Labai gryno prasugrelio hidrochlorido gavimo būdas
IL200647A0 (en) Method for producing high purity prasugrel hydrochloride
PT2119672T (pt) Processo para produzir alpha-alumina de elevada pureza
ZA200809118B (en) Process for hydrogen production
AP2009004829A0 (en) Process for producing theaflavins
PL2159292T3 (pl) Sposób wytwarzania kształtowanego wyrobu
PL2213654T3 (pl) Sposób wytwarzania pochodnych 2-amino-5-bromobenzamidu
IL225873A0 (en) Process for the production of trazodone and trazodone hydrochloride
EP2088136A4 (en) PROCESS FOR PRODUCING HYDROXYADAMANTANE-AMINE
ZA200808505B (en) Process for producing high-purity prasugrel and acid addi-tion salt thereof
IL192702A0 (en) Process for producing 5-alkoxy-4-hydroxymethylpyrazole compound
IL193246A0 (en) A process for producing nitroisourea derivatives
IL196270A0 (en) Process for preparing clopidogrel bisulphate
SG136087A1 (en) Process for producing methionine
ZA200806841B (en) Process for producing o-methyl-n-nitroisourea
HUP0700461A2 (en) Process for producing 9alpha-hydroxy-steroids
IL195262A0 (en) Process for preparing hydroxylpatite
ZA200903986B (en) Process for producing anthranilamide compound
IL196719A0 (en) Process for preparing amorphous lercanidipine hydrochloride
EP2181125A4 (en) PROCESS FOR PRODUCING HIGH-PURITY EXO-ALKENYLNORBORNENES
EP2082010A4 (en) PROCESS FOR PRODUCING IMPROVED OLEFINS
HU0700411D0 (en) Process for producing quetiapin
EP2114883A4 (en) PROCESS FOR THE PREPARATION OF LERCANIDIPINE HYDROCHLORIDE
IL182134A0 (en) Process for production of 2-chloro-4-nitroimidazole
ZA200904567B (en) Process for producing 2-isopropenyl-5-methyl-4-hexene-1-yl-3-methyl-2-butenoate